Clinical Trials

The Canadian Cancer Trials Group (CCTG) supports national and international multicentre phase I-III cancer clinical research trials aimed at improving the survival and quality of life of cancer patients across all cancer types. The scientific agenda for the group is developed by clinical researchers across Canada and beyond, includes trials of new cancer agents, novel radiation and surgical techniques, as well as interventions to improve patient quality of life.

If you are a CCTG member and need to access the full trials pages please click here.

The links below will take you to pages that list all the current CCTG trials with a brief description. If you are interested in volunteering for a trial we suggest that you discuss the opportunity with your care team.

If you are a patient or caregiver and are looking for other information about clinical trials a complete listing of clinical trials being conducted in Canada, including the locations where they are being conducted, can be found here: Canadian Cancer Trials.  And if you are interested in learning about participating in a clinical trial more information can be found here: www.itstartswithme.ca

 

 

EN10 A gynecological cancer clinical trial

CCTG EN10 study is tailoring therapy for post-surgical patients with low-risk endometrial cancer

EN10 (RAINBO BLUE & TAPER) is a new Canadian clinical trial that is applying state-of-the-art molecular testing to classify post-surgery treatments in early-stage endometrial cancer to identify people at low risk of cancer recurrence based on the molecular features of their tumours.

More >>
 
CCTG PR24 ASCENDE-SBRT trial aims to treat prostate cancer

CCTG PR24 ASCENDE-SBRT trial aims to treat prostate cancer with improved precision

A new Canadian trial designed and led by Sunnybrook Health Sciences Centre will determine whether Stereotactic Ablative Body Radiotherapy (SABR) can replace the standard brachytherapy boost for men with unfavourable risk prostate cancer.

More >>
 
Three trials funded GU ASCENDE, IND241 SURELY, EN11 RAINBO-GREEN

CIHR SUCCESS with 7.5 million for three trials: GU ASCENDE, IND241 SURELY, EN11 RAINBO-GREEN

Three CCTG trials were recently awarded nearly $7.5M from the Canadian Institutes of Health Research (CIHR) 2022 Spring Project Grant competition.

More >>
 
Solving Cancer Together - CCTG Strategic Plan 2022-2027

Solving Cancer Together - CCTG Strategic Plan 2022-2027

The new CCTG Strategic Plan: Solving Cancer Together articulates the scientific priorities and required supporting activities that would lead the Group through to 2027. Our new scientific priorities: Understand Cancer Biology, Reduce the Cancer Burden, and Improve Cancer Care with their associated objectives and activities will lead to new advances in innovative therapies, understanding resistance, reduce the burdens of cancer, and show the value of these innovations.

More >>